It is a privilege for me to be involved in a patient’s cancer care. I believe that quality cancer care is important, but it needs to be delivered in the context of the patient’s overall health and goals. To me, gaining or maintaining quality of life is as important as gaining quantity of life.
Dr. Dash has experience in all areas of urologic oncology such as the surgical treatment of prostate, renal, testis and bladder cancers with the use of continent urinary diversion for reconstruction after cystectomy. He uses the da Vinci robotic system to perform laparoscopic operations, including radical prostatectomy, radical cystecomy, and partial nephrectomy.
Dr. Dash’s clinical research has focused on prostate, bladder, kidney and testis cancers. His laboratory research has focused on molecular aspects of prostate and bladder cancer including application of microarray technology. His clinical and laboratory research have been published in peer reviewed publications.
Dr. Dash attended medical school at University of Vermont College of Medicine. He completed his residency at University of Michigan and his fellowship at Memorial Sloan-Kettering Cancer Center.
Dr. Dash is board certified by the American Board of Urology.